We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Efficacy of 308nm Excimer Laser in White Striae

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00361361
First Posted: August 8, 2006
Last Update Posted: February 20, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Shahid Beheshti University of Medical Sciences
  Purpose
The purpose of this study is to determine whether 308nm Excimer Laser therapy are effective in the color correction of white striae.

Condition Intervention Phase
White Striae Excimer Laser Device: Excimer Laser Therapy Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Efficacy of 308nm Excimer Laser in White Striae

Further study details as provided by Shahid Beheshti University of Medical Sciences:

Primary Outcome Measures:
  • Clinical darkening of striaes

Secondary Outcome Measures:
  • Colorimetric assessment

Estimated Enrollment: 10
Study Start Date: July 2006
Study Completion Date: October 2006
Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Excimer Laser Therapy
    excimer laser is a UV 308nm laser. repeated sessions (10 sessions) needed. once per week.
Detailed Description:
The use of excimer laser in modified program in white striae during a few months.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • White Striae

Exclusion Criteria:

  • Red Striae
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00361361


Locations
Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University
Tehran, Iran, Islamic Republic of, 19899
Sponsors and Collaborators
Shahid Beheshti University of Medical Sciences
Investigators
Study Director: Nima Ostovari, M.D. Shahid Beheshti University of Medical Sciences
Study Chair: Parviz Toossi, MD skin research center of shaheed-beheshti medical university
  More Information

Responsible Party: Dr.Nima Ostovari
ClinicalTrials.gov Identifier: NCT00361361     History of Changes
Other Study ID Numbers: src-ost-1360
First Submitted: August 7, 2006
First Posted: August 8, 2006
Last Update Posted: February 20, 2008
Last Verified: November 2006